WuXi PharmaTech Cayman is a holding company. Through its subsidiaries, the Company is engaged in pharmaceutical, biotechnology and medical device research and development outsourcing, with operations in the People's Republic of China and the United States. The Company provides an integrated portfolio of laboratory and manufacturing services throughout the drug and medical device research and development process to the Company's customers, which include pharmaceutical, biotechnology and medical device companies. The Company conducts its operations in two segments: laboratory services and manufacturing services.Data provided by Mergent, Inc.
|DR Exchange||New York Stock Exchange|
|Effective Date||Aug 14, 2007|
|Local Exchange||Not Traded|
|Industry||Pharma. & Biotech.|